[01] Joanna Cholewa, Department of Physiotherapy in Neurological and Musculoskeletal Disorders, J. Kukuczka Academy of Physical Education in Katowice, Katowice, Poland. [02] Marcin Kunicki, Department of Physical Education, State Higher Vocational School in Raciborz, Racibórz, Poland. [03] Jarosław Cholewa, Department of Physical Education, J. Kukuczka Academy of Physical Education in Katowice, Katowice, Poland.

Introduction: In addition to the significant role of physical rehabilitation as a non-pharmacological treatment for Parkinson's disease (PD), positive impact of various forms of physical activity (PA) in slowing down of the disease should be pointed out. There is a lack of research on the topic of physical activity undertaken by people with Parkinson's disease, which is part of lifestyle. Aim: The aim of the study was to determine the level of physical activity of people suffering from Parkinson's disease who were participating and were not participating in the rehabilitation process compared to healthy people. Methods: The study included 66 people diagnosed with PD in II stage of the disease according to the Hoehn and Yahr scale and 50 healthy people. The subjects were divided into 3 groups: group A - subjects with PD participating in the rehabilitation activities (n=32, 14 women, 18 men, at the age of 61.31±4.64 years, disease duration at the 5.13±4.83), group B - people with PD non- participating in the rehabilitation activities (n=34, 15 women, 19 men, at the age of 62.65±4.84 years, disease duration at the 5.76±3.45), group C - healthy people (n=50, 27 women, 23 men, age 60.95±3.68). To assess the level of PA the short version of the International Physical Activity Questionnaire (IPAQ) was used and a weekly volume of physical activity in the 3 zones of intensity was set. The intensity of effort was determined by using a metabolic equivalent (metabolic equivalent - MET). Results: Analysis of the level of PA showed statistically significant differences between groups A and B, and A and C in all zones of intensity. No statistically significant differences were found between groups A and C. Analysis of weekly volume of PA showed a statistically significant differences between groups A and B (F=3.56, p<0.001), and B and C (F=2.43, p<0.002). No statistically significant difference was observed between groups A and C (F=5.78, p<0.02). Conclusion: The level of physical activity of people with PD varies depending on participation in the rehabilitation process. Physical activity of people with PD participating in the rehabilitation process is at a comparable level to healthy people.

Physical Activity of People with Parkinson’s Disease with Regard to Participation in Rehabilitation Program

[01] Ainsworth B.E., Haskell W.L., Whitt M.C., Irwin M.L., Swartz A.M., Strath S.J. at all. (2000): Compedium of physical activities: an update of activity codes and MET intensities. Medicine Science Sports Exercise, 32(9), 498–516 [02] Baizabal-Carvallo J.F., Kagnoff M.N., Jimenez-Shahed J., Fekete R., Jankovic J.(2014): The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. Journal of Neurology, Neurosurgery and Psychiatry, 85(5), 567-572. [03] Bauman A., Bull F., Cheyl T., Craig C.L., Ainsworth B.E., Sallis J.F., Bowles H.R. Hagstromer M., Sjostrom M., Pratt M. (2009): The International Prevalence Study on Physical Activity: results from 20 countries. International Journal of Behavioral Nutrition and Physical Activity, 31, 6-21. [04] Benito-Leon J., Bermejo-Pareja F., Morales-Gonzales J.M., Porta-Etessam J., Trincado R. et al. (2004): Neurological Disorders in Central Spain (NEDICES) Study Group: Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology, 62: 734-741. [05] Bloem B.R., van Vugt J.P., Beckley D.J. (2001): Postural instability and falls in Parkinson’s disease. [In:] Ruzicka E, Hallett M, Jankovic J, eds. Advances in Neurology: Gait Disorders. Philadelphia, Lippincott Williams and Wilkins. [06] Cholewa J., Gorzkowska A., Szepelawy M., Nawrocka A., Cholewa J. (2014): Influence of functional Movement Rehabilitation on Quality of Life in people with Parkinson’s disease. Journal of Physical Therapy Science, 26(9), 1329-1331. [07] Cholewa J. (2014): Rehabilitation Procedures Aimed at Decreasing Motor Symptoms in Parkinson’s Disease. International Journal of Physical Medicine and Rehabilitation, S5, 009. [08] Connolly B.S., Lang A.E. (2014): Pharmacological treatment of Parkinson disease: a review. The Journal of The American Medical Association, 311(16), 1670-1683. [09] Cruise K.E., Bucks R.S., Loftus A.M. et al. (2011): Exercise and Parkinson’s: benefits for cognition and quality of life. Acta Neurologica Scandinavica, 123(1): 13-19. [10] Dorsey E.R., Constantinescu R., Thompson J.P., Biglan K.M., Holloway R.G., Kieburtz K., Marshall F.J., Ravina B.M., Schifitto G., Siderowf A., Tanner C.M. (2007): Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68(5), 384-386. [11] Earhart G.M., Williams A.J. (2012): Treadmill training for individuals with Parkinson disease. Physical Therapy, 92: 893-897. [12] Fearnley J.M., Lees A.J. (1991): Ageing and Parkinson’s disease: substantial nigra regional selectivity. Brain 114, 2283-2301. [13] Franchignoni F., Martignoni E., Ferriero G., Pasetti C. (2005): Balance and fear of falling in Parkinson’s disease. Parkinsonism and Related Disorders, 11, 427–433. [14] Hoehn H., Yahr M. (1967): Parkinsonism: onset, progression and mortality. Neurology, 17, 427-42. [15] Kuroda K., Tatara K., Takatorige T., Shinsho F: (1992): Effect of physical exercise on mortality in patients with Parkinson’s disease. Acta Neurologica Scandinavica, 86(1), 55-9. [16] Morris M.E. (2000): Movement disorders in people with Parkinson disease: a model for physical therapy. Physical Therapy 80(6), 578-597. [17] Olanow C.W., Stern M.B., Sethi K. (2009): The scientific and clinical basis for the treatment of Parkinson disease. Neurology, 72 (21 suppl 4): S1-136. [18] Olanow W.C., Agid Y., Mizuno Y., Albanese U., Damier Ph. et al (2004): Levodopa in the treatment of Parkinson’s disease: current controversies. Movement Disorders, 19(9), 997-1005. [19] Pals P., van Everbroeck B., Grubben B., Viaene M.K., Dom R. et al. (2003): Case - control study of environmental risk factors for Parkinson’s disease in Belgium. European Journal of Epidemiology, 18, 1133-1142. [20] Sarbadhikari S.N., Saha A.K., (2006): Moderate exercise and chronic stress produce counteractive effects on different areas of the brain by acting through various neurotransmitter receptor subtypes: a hypothesis. Theoretical Biology and Medical Modelling, 3, 33. [21] Schenkman M., Hall D.A., Baron A.E., Schwartz R.S. et al. (2012): Exercise for people in early or mid-stage Parkinson disease: A 16-month randomized controlled trial. Physical Therapy, 92, 1395-1410. [22] Speelman A.D., van de Warrenburg B.P., van Nimwegen M. et al. (2011): How might physical activity benefit patients with Parkinson disease? Nature Reviews Neurology, 7(9), 528-534. [23] Tomlison C.L., Patel S., Meek C., Herd C.P., Clarke C.E. et al. (2012): Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. British Medical Association 345, e5004. [24] Uitti R J. (2012): Treatment of Parkinson’s disease: focus on quality of life issues. Parkinsonism Related Disorders, 18 suppl 1, S34-36. [25] Van Nimvegen M., Speelman A.D., Hofman-van Rossum E.J. et al. (2011): Physical inactivity in Parkinson’s disease. Journal of Neurology, 258(12):2214-2224. [26] Wirdefeldt K., Adami H.O., Cole P., Trichopoulos D., Mandel J. (2011): Epidemiology and etiology of Parkinson’s disease: a review of the evidence. European Journal of Epidemiology, 26 suppl 1, S1-58.